Koninklijke Philips (NYSE:PHG – Get Free Report) has been given a consensus rating of “Hold” by the four research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company.
A number of equities analysts recently weighed in on PHG shares. JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. StockNews.com raised shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 8th. BNP Paribas cut Koninklijke Philips from an “outperform” rating to an “underperform” rating in a report on Wednesday, February 7th. Finally, UBS Group upgraded Koninklijke Philips from a “sell” rating to a “neutral” rating in a research note on Tuesday, April 30th.
Read Our Latest Research Report on Koninklijke Philips
Institutional Inflows and Outflows
Koninklijke Philips Stock Up 0.3 %
NYSE:PHG opened at $26.90 on Tuesday. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $29.44. The firm has a market capitalization of $24.98 billion, a price-to-earnings ratio of -28.02, a price-to-earnings-growth ratio of 1.39 and a beta of 0.75. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. The stock’s 50 day moving average price is $21.22 and its two-hundred day moving average price is $21.27.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Value Stocks You Can Buy Before They Become Big
- Why Are Stock Sectors Important to Successful Investing?
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.